SESSION TITLE: Cardiovascular Disease
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Many patients requiring implants of Cardiac Implantable Electronic Devices (CIED) are also on oral anticoagulant, warfarin (OAC). Peri-operative management for these patients has evolved from normalizing their anticoagulation to an appropriate level (INR<1.5) to performing CIED procedures while therapeutic on OAC. To assess the safety and impact this new practice has had on our community, we evaluated the outcomes of this new paradigm in peri-operative OAC management at a large public hospital system.